Dhaka [Bangladesh], January 8 (ANI): Bangladesh on Thursday approved procurement of 30 million doses of Covishield COVID-19 vaccine from India, co-developed by European pharmaceutical company AstraZeneca and Oxford University.
New Delhi [India], January 6 (ANI): Demanding that there should be no politics over the COVID-19 vaccine, CPI-M general secretary Sitaram Yechury has urged the central government to share the scientific proof of the vaccine to start the vaccination drive.
New Delhi [India], January 6 (ANI): Congress leader Manish Tewari on Tuesday said that the Bharatiya Janata Party (BJP) government has "politically misused" the COVID-19 pandemic and raised question marks on the reliability of the vaccine.
Pune/Hyderabad [India], January 5 (ANI): Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world.
New Delhi [India], January 3 (ANI): As the COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in an emergency situation, Union Health Minister Dr Harsh Vardhan on Sunday termed it as "watershed moment" in India's battle against COV
New Delhi [India], January 3 (ANI): Union Home Minister Amit Shah and Bharatiya Janata Party (BJP) chief JP Nadda on Sunday hailed the country's scientists and frontline workers after the Drugs Controller General of India (DCGI) approved the Serum Institue of India and Bharat Biotech's CO
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.
New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
New Delhi [India], December 29 (ANI): Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melin
Pune (Maharashtra) [India], December 28 (ANI): Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's first indigenously developed pneumococcal vaccine - PNEUMOSIL.